These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 35385746)

  • 21. Endothelial cell sprouting driven by RhoJ directly activated by a membrane-anchored Intersectin 1 (ITSN1) RhoGEF module.
    Color-Aparicio VM; Cervantes-Villagrana RD; García-Jiménez I; Beltrán-Navarro YM; Castillo-Kauil A; Escobar-Islas E; Reyes-Cruz G; Vázquez-Prado J
    Biochem Biophys Res Commun; 2020 Mar; 524(1):109-116. PubMed ID: 31980169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of the Pol II CTD Phosphorylation Code by Rac1 and Cdc42 Small GTPases in Cultured Human Cancer Cells and Its Implication for Developing a Synthetic-Lethal Cancer Therapy.
    Zhang B; Zhong X; Sauane M; Zhao Y; Zheng ZL
    Cells; 2020 Mar; 9(3):. PubMed ID: 32143485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting Cdc42 with the small molecule drug AZA197 suppresses primary colon cancer growth and prolongs survival in a preclinical mouse xenograft model by downregulation of PAK1 activity.
    Zins K; Gunawardhana S; Lucas T; Abraham D; Aharinejad S
    J Transl Med; 2013 Nov; 11():295. PubMed ID: 24279335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maintenance of CDC42 GDP-bound state by Rho-GDI inhibits MAP kinase activation by the exchange factor Ras-GRF. evidence for Ras-GRF function being inhibited by Cdc42-GDP but unaffected by CDC42-GTP.
    Arozarena I; Matallanas D; Crespo P
    J Biol Chem; 2001 Jun; 276(24):21878-84. PubMed ID: 11285260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporally and spatially coordinated roles for Rho, Rac, Cdc42 and their effectors in growth cone guidance by a physiological electric field.
    Rajnicek AM; Foubister LE; McCaig CD
    J Cell Sci; 2006 May; 119(Pt 9):1723-35. PubMed ID: 16595546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cdc42 Signaling Pathway Inhibition as a Therapeutic Target in Ras- Related Cancers.
    Aguilar BJ; Zhou H; Lu Q
    Curr Med Chem; 2017; 24(32):3485-3507. PubMed ID: 28571533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of activated Rac1/Cdc42 in mediating endothelial cell proliferation and tumor angiogenesis in breast cancer.
    Ma J; Xue Y; Liu W; Yue C; Bi F; Xu J; Zhang J; Li Y; Zhong C; Chen Y
    PLoS One; 2013; 8(6):e66275. PubMed ID: 23750283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study.
    Makrodouli E; Oikonomou E; Koc M; Andera L; Sasazuki T; Shirasawa S; Pintzas A
    Mol Cancer; 2011 Sep; 10():118. PubMed ID: 21943101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of CDC42 Inhibitors with a Favorable Pharmacokinetic Profile and Anticancer In Vivo Efficacy.
    Brindani N; Vuong LM; La Serra MA; Salvador N; Menichetti A; Acquistapace IM; Ortega JA; Veronesi M; Bertozzi SM; Summa M; Girotto S; Bertorelli R; Armirotti A; Ganesan AK; De Vivo M
    J Med Chem; 2024 Jun; 67(12):10401-10424. PubMed ID: 38866385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic activation of p21-activated kinase 1 by phosphatidylinositol 4,5-bisphosphate and Rho GTPases.
    Malecka KA; Szentpetery Z; Peterson JR
    J Biol Chem; 2013 Mar; 288(13):8887-97. PubMed ID: 23393142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Small Rho GTPase TC10 Modulates B Cell Immune Responses.
    Burbage M; Keppler SJ; Montaner B; Mattila PK; Batista FD
    J Immunol; 2017 Sep; 199(5):1682-1695. PubMed ID: 28747344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E-cadherin negatively regulates neoplastic growth in non-small cell lung cancer: role of Rho GTPases.
    Asnaghi L; Vass WC; Quadri R; Day PM; Qian X; Braverman R; Papageorge AG; Lowy DR
    Oncogene; 2010 May; 29(19):2760-71. PubMed ID: 20228844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A role of STAT3 in Rho GTPase-regulated cell migration and proliferation.
    Debidda M; Wang L; Zang H; Poli V; Zheng Y
    J Biol Chem; 2005 Apr; 280(17):17275-85. PubMed ID: 15705584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arhgef15 promotes retinal angiogenesis by mediating VEGF-induced Cdc42 activation and potentiating RhoJ inactivation in endothelial cells.
    Kusuhara S; Fukushima Y; Fukuhara S; Jakt LM; Okada M; Shimizu Y; Hata M; Nishida K; Negi A; Hirashima M; Mochizuki N; Nishikawa S; Uemura A
    PLoS One; 2012; 7(9):e45858. PubMed ID: 23029280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cdc42 and k-Ras Control Endothelial Tubulogenesis through Apical Membrane and Cytoskeletal Polarization: Novel Stimulatory Roles for GTPase Effectors, the Small GTPases, Rac2 and Rap1b, and Inhibitory Influence of Arhgap31 and Rasa1.
    Norden PR; Kim DJ; Barry DM; Cleaver OB; Davis GE
    PLoS One; 2016; 11(1):e0147758. PubMed ID: 26812085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rho family GTPases regulate mammary epithelium cell growth and metastasis through distinguishable pathways.
    Bouzahzah B; Albanese C; Ahmed F; Pixley F; Lisanti MP; Segall JD; Condeelis J; Joyce D; Minden A; Der CJ; Chan A; Symons M; Pestell RG
    Mol Med; 2001 Dec; 7(12):816-30. PubMed ID: 11844870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Rho GTPases in breast cancer.
    Tang Y; Olufemi L; Wang MT; Nie D
    Front Biosci; 2008 Jan; 13():759-76. PubMed ID: 17981586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA.
    Edlund S; Landström M; Heldin CH; Aspenström P
    Mol Biol Cell; 2002 Mar; 13(3):902-14. PubMed ID: 11907271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis.
    Guo Y; Kenney SR; Muller CY; Adams S; Rutledge T; Romero E; Murray-Krezan C; Prekeris R; Sklar LA; Hudson LG; Wandinger-Ness A
    Mol Cancer Ther; 2015 Oct; 14(10):2215-27. PubMed ID: 26206334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cdc42 functions as a regulatory node for tumour-derived microvesicle biogenesis.
    Wang J; Zhuang X; Greene KS; Si H; Antonyak MA; Druso JE; Wilson KF; Cerione RA; Feng Q; Wang H
    J Extracell Vesicles; 2021 Jan; 10(3):e12051. PubMed ID: 33473262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.